You are here

Article Text

Article menu
Download PDFPDF
Letter
Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion
  1. S D M Chen,
  2. J Lochhead,
  3. C K Patel,
  4. P Frith
  1. Oxford Eye Hospital, Oxford, UK
  1. Correspondence to: Simon Chen Oxford Eye Hospital, Woodstock Road, Oxford OX2 6HE, UK; s-chenrocketmail.com

https://doi.org/10.1136/bjo.88.1.154

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    No proved treatment exists for ischaemic macular oedema associated with branch retinal vein occlusion (BRVO) despite the potential for significant visual loss in affected eyes.

    We report a patient with an ischaemic BRVO with associated macular oedema treated with intravitreal triamcinolone acetonide.

    Case report

    A 38 year old man was referred to our department with a 6 week history of acute visual loss in his right eye (RE). On examination, visual acuity was 6/60 RE and 6/6 LE. A right relative afferent pupillary defect was present. Intraocular pressures were 9 and 10 mm Hg, respectively. Anterior segment examination showed no evidence of neovascularisation. There was no vitreous inflammation. Dilated fundus examination revealed a right inferotemporal BRVO with macular oedema. Collateral disc vessels were present. Systemic and haematological examinations, including full blood count, erythrocyte sedimentation rate, C-reactive protein, clotting screen, serum angiotensin converting enzyme, serum cholesterol and triglycerides, clotting screen, chest x ray, and ECG, were negative for systemic …

    View Full Text